Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells

Although docetaxel-based regimens are common and effective for early-stage triple-negative breast cancer (TNBC) treatment, acquired drug resistance frequently occurs. Therefore, a novel therapeutic strategy for docetaxel-resistant TNBC is urgently required. Signal transducer and activator of transcr...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Woong Sub, Bae, Eun Seo, Cui, Jinsheng, Park, Hyen Joo, Oh, Dong-Chan, Lee, Sang Kook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074004/
https://www.ncbi.nlm.nih.gov/pubmed/33920736
http://dx.doi.org/10.3390/biomedicines9040436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074004/
https://www.ncbi.nlm.nih.gov/pubmed/33920736
http://dx.doi.org/10.3390/biomedicines9040436

Ejemplares similares